IP Library Granted Patent US 8,460,892
Granted Patent B2
US 8,460,892 · App. 12/477,704 · Granted Jun 11, 2013

Detecting infection in reduced pressure wound treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,460,892
App. No.
12/477,704
Granted
Jun 11, 2013
Kind
B2
Abstract

Provided is a method of detecting infection in a wound caused by an infecting organism at a wound site. Also provided is a system for detecting an infection in a wound at a wound site. Additionally, a porous pad comprising luciferase is provided.

Claims (37)

1. A method of detecting infection in a wound caused by an infecting organism at a wound site, the method comprising:

applying a reduced pressure to the wound site from an apparatus comprising:

a source of reduced pressure;

a porous pad adapted to deliver the reduced pressure to the wound site, wherein the porous pad comprises luciferase and luciferin;

a conduit fluidly connecting the porous pad to the source of reduced pressure; and

a photodetector capable of measuring light;

withdrawing fluid from the wound site in response to the reduced pressure;

assaying the fluid from the wound site for a product of the infection, by measuring light emitted from the fluid with said photodetector; and

identifying increasing concentrations of the product of infection indicative of an infection in the wound.

2. The method of claim 1 , wherein the infecting organism is a bacterium.

3. The method of claim 1 , wherein the wound comprises a tissue selected from the group consisting of dermal tissue, bone tissue, cartilage, tendon, ligament, muscle, nerve tissue, subcutaneous tissue, and adipose tissue.

4. The method of claim 1 , wherein the product of the infection is adenosine-5′-triphosphate (ATP).

5. The method of claim 1 , wherein assaying the fluid comprises measuring light produced by combining the product of the infection with luciferase and luciferin.

6. The method of claim 4 , wherein identifying increasing concentrations comprises quantifying the ATP by measuring light produced in a reaction between the fluid withdrawn, luciferase, and luciferin.

7. The method of claim 1 , wherein the apparatus further comprises a reservoir adapted for collection of the fluid.

8. The method of claim 1 , wherein the luciferase is covalently bound to the porous pad.

9. The method of claim 1 , wherein the apparatus further comprises a computer linked to the photodetector, wherein the computer is capable of recording the light measurements from the photodetector.

10. The method of claim 9 , wherein the computer is further capable of determining whether the recorded light measurements indicate infection in the wound.

11. The method of claim 1 , wherein the apparatus further comprises a supply line into the porous pad for the introduction of an infection-controlling compound to the wound.

12. A method of detecting infection in a wound caused by an infecting organism at a wound site, the method of comprising:

providing fluid collection from a wound site in response to reduced pressure applied to the wound site from an apparatus comprising:

a source of reduced pressure;

a porous pad adapted to deliver the reduced pressure to the wound site wherein the porous pad comprises luciferase and luciferin;

a conduit fluidly connecting the porous pad to the source of reduced pressure; and

a photodetector capable of measuring light;

assaying the fluid collected from the wound site for a product of the infection with said photodetector; and

identifying increasing concentrations of the product of infection indicative of an infection in the wound.

13. The method of claim 12 , wherein the wound comprises a tissue selected from the group consisting of dermal tissue, bone tissue, cartilage, tendon, ligament, muscle, nerve tissue, subcutaneous tissue, and adipose tissue.

14. The method of claim 12 , wherein the product of the infection is adenosine-5′-triphosphate (ATP).

15. The method of claim 14 , wherein identifying increasing concentrations comprises measuring light produced in a reaction between the fluid withdrawn, luciferase, and luciferin to quantify the ATP.

16. The method of claim 14 , wherein assaying the fluid collected comprises combining the fluid collected with luciferase and luciferin to produce a reaction, and then measuring light produced from the reaction to detect the ATP.

17. The method of claim 12 , wherein identifying increasing concentrations comprises quantifying the ATP by measuring light produced in a reaction between the fluid withdrawn, luciferase, and luciferin.

18. The method of claim 12 , wherein the apparatus further comprises a computer linked to the photodetector, wherein the computer is capable of recording the light measurements from the photodetector.

19. The method of claim 18 , wherein the computer is further capable of determining whether the recorded light measurements indicate infection in the wound.

20. The method of claim 12 , wherein the apparatus further comprises a supply line into the porous pad for the introduction of an infection-controlling compound to the wound.

21. The method of claim 1 or 12 , wherein the apparatus further comprises a drape.

22. The method of claim 21 , wherein the photodetector is integrated with the drape.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066445/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →